ClinTec International is a global clinical research organisation, which was founded in 1997 by Dr Rabinder Buttar, the company's President and CEO. ClinTec International has a presence in 33 developed and emerging countries, covering Western Europe, Central & Eastern Europe, Middle East and North Africa, Central and South Africa, Latin America, India and the US.  In addition to ClinTec' vast expertise in oncology, it has also conducted over a 150 clinical trials in many other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology.

ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world class project managers, country managers and clinical research associates. ClinTec International's 'fast, flexible and focused' approach to clinical research ensures an added advantage to the drug development process.

ClinTec International provides clinical research and resourcing services for the conduct of phase I - IV clinical trials worldwide.

http://www.clintec.com